Marta
Santisteban Eslava
Consultora Médica
![Foto de Marta](/img/nophoto.png)
![Foto de University of Pittsburgh](/img/noimage_org.png)
University of Pittsburgh
Pittsburgh, Estados UnidosPublications en collaboration avec des chercheurs de University of Pittsburgh (1)
2022
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268